MAPT and Alzheimer disease: Specifically, soluble triggering receptor expressed on myeloid cells 2–related neuroinflammation is linked to stronger Aβ‐related p‐tau increases in women versus men61 and female AD patients exhibit a heightened neuroinflammatory response on translocator protein PET, which is linked to greater fibrillar tau.66